ProfileGDS4718 / 231906_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 71% 82% 91% 68% 73% 80% 56% 80% 72% 76% 76% 62% 45% 58% 58% 75% 80% 69% 78% 82% 75% 74% 76% 75% 72% 68% 75% 83% 73% 84% 55% 88% 76% 72% 80% 81% 84% 76% 81% 90% 81% 51% 90% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.969571
GSM549102patient 115, normal, homogenized [OPG study]7.9826582
GSM549104patient 119, normal, homogenized [OPG study]9.4938491
GSM549108patient 138, normal, homogenized [OPG study]6.6610768
GSM549119patient 077, normal, homogenized [OPG study]7.0978673
GSM549133patient 032, cancer, homogenized [OPG study]8.0347380
GSM549139patient 042, cancer, homogenized [OPG study]5.8771456
GSM549099patient 107, normal, homogenized [OPG study]7.7515880
GSM549109patient 139, normal, homogenized [OPG study]7.0634272
GSM549110patient 046, normal, homogenized [OPG study]7.3862176
GSM549114patient 063, normal, homogenized [OPG study]7.4700476
GSM549122patient 082, normal, homogenized [OPG study]6.2937362
GSM549134patient 033, cancer, homogenized [OPG study]5.2470345
GSM549136patient 036, cancer, homogenized [OPG study]5.9331858
GSM549140patient 044, cancer, homogenized [OPG study]5.9566758
GSM549111patient 047, normal, homogenized [OPG study]7.4039575
GSM549113patient 057, normal, homogenized [OPG study]7.9995380
GSM549132patient 031, cancer, homogenized [OPG study]6.7903369
GSM549137patient 038, cancer, homogenized [OPG study]7.6715978
GSM549142patient 047, cancer, homogenized [OPG study]7.7656682
GSM549100patient 110, normal, homogenized [OPG study]7.2333775
GSM549107patient 135, normal, homogenized [OPG study]7.2390774
GSM549115patient 068, normal, homogenized [OPG study]7.454576
GSM549116patient 072, normal, homogenized [OPG study]7.3801675
GSM549120patient 078, normal, homogenized [OPG study]7.0247672
GSM549131patient 030, cancer, homogenized [OPG study]6.7558268
GSM549118patient 074, normal, homogenized [OPG study]7.3209375
GSM549129patient 027, cancer, homogenized [OPG study]8.2010383
GSM549123patient 088, normal, homogenized [OPG study]7.1121973
GSM549124patient 006, cancer, homogenized [OPG study]8.2305184
GSM549126patient 015, cancer, homogenized [OPG study]5.8176855
GSM549128patient 025, cancer, homogenized [OPG study]8.9077188
GSM549103patient 117, normal, homogenized [OPG study]7.2813776
GSM549117patient 073, normal, homogenized [OPG study]6.9872672
GSM549138patient 041, cancer, homogenized [OPG study]7.9341480
GSM549141patient 045, cancer, homogenized [OPG study]8.1142181
GSM549130patient 028, cancer, homogenized [OPG study]8.225484
GSM549101patient 111, normal, homogenized [OPG study]7.4316476
GSM549105patient 128, normal, homogenized [OPG study]7.902881
GSM549106patient 134, normal, homogenized [OPG study]9.2998990
GSM549112patient 048, normal, homogenized [OPG study]8.0408181
GSM549125patient 011, cancer, homogenized [OPG study]5.5874851
GSM549127patient 024, cancer, homogenized [OPG study]9.1301890
GSM549135patient 035, cancer, homogenized [OPG study]8.0817181